MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed on Euronext Paris (ticker: MAAT) since 2021.
Company Details
- Employees
- 85
- Founded
- -
- Address
- 70 Avenue Tony Garnier, Lyon,69007,france
- Phone
- +33 9 53 41 39 65
- Co****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- maatpharma.com
- Keywords
- Microbiome, Microbiota, Microbiology, pharma, GvHD, Leukemia, Dysbiosis, Symbiosis, Biotech, oncology, cancer, gut microbiota, allo-HSCT, Gut microbiome, Immune modulation, Blood cancers.
- HQ
- Lyon
Maat Pharma Questions
Maat Pharma's helpline number is +33 9 53 41 39 65
Maat Pharma's website is maatpharma.com
Maat Pharma's LinkedIn profile is https://fr.linkedin.com/company/maat-pharma
Maat Pharma has
85 employees.
View email and phone details for 85
employees at Maat Pharma.
Maat Pharma's industry is
Biotechnology Research
Maat Pharma's top competitors are
Theranexus,
Enyo Pharma,
Adocia,
Transgene,
Ose Immunotherapeutics,
Innate Pharma,
Bioaster,
Phaxiam Therapeutics,
Cellectis,
Abivax.
Maat Pharma's support email address is Contact@maat-pharma.com
Maat Pharma's categories are Biotechnology Research
Maat Pharma's founding year is 2014
